FRA:MED Statistics

Total Valuation

FRA:MED has a market cap or net worth of EUR 148.20 million. The enterprise value is 500.54 million.

Market Cap	148.20M
Enterprise Value	500.54M

Important Dates

The next estimated earnings date is Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	Jun 5, 2025

Share Statistics

Current Share Class	47.50M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	11.44M

Valuation Ratios

The trailing PE ratio is 5.68.

PE Ratio	5.68
Forward PE	n/a
PS Ratio	0.19
PB Ratio	0.66
P/TBV Ratio	0.74
P/FCF Ratio	3.63
P/OCF Ratio	1.84
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.89, with an EV/FCF ratio of 12.25.

EV / Earnings	19.20
EV / Sales	0.66
EV / EBITDA	4.89
EV / EBIT	9.74
EV / FCF	12.25

Financial Position

The company has a current ratio of 1.81, with a Debt / Equity ratio of 2.04.

Current Ratio	1.81
Quick Ratio	1.73
Debt / Equity	2.04
Debt / EBITDA	4.46
Debt / FCF	11.19
Interest Coverage	2.33

Financial Efficiency

Return on equity (ROE) is 12.52% and return on invested capital (ROIC) is 4.76%.

Return on Equity (ROE)	12.52%
Return on Assets (ROA)	3.57%
Return on Invested Capital (ROIC)	4.76%
Return on Capital Employed (ROCE)	7.01%
Revenue Per Employee	104,536
Profits Per Employee	3,576
Employee Count	10,472
Asset Turnover	0.85
Inventory Turnover	80.95

Taxes

In the past 12 months, FRA:MED has paid 7.09 million in taxes.

Income Tax	7.09M
Effective Tax Rate	21.26%

Stock Price Statistics

The stock price has increased by +30.17% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+30.17%
50-Day Moving Average	2.97
200-Day Moving Average	2.72
Relative Strength Index (RSI)	50.82
Average Volume (20 Days)	7,540

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:MED had revenue of EUR 762.28 million and earned 26.08 million in profits. Earnings per share was 0.55.

Revenue	762.28M
Gross Profit	165.08M
Operating Income	51.39M
Pretax Income	33.34M
Net Income	26.08M
EBITDA	73.58M
EBIT	51.39M
Earnings Per Share (EPS)	0.55

Full Income Statement

Balance Sheet

The company has 105.03 million in cash and 457.06 million in debt, giving a net cash position of -352.03 million.

Cash & Cash Equivalents	105.03M
Total Debt	457.06M
Net Cash	-352.03M
Net Cash Per Share	n/a
Equity (Book Value)	223.81M
Book Value Per Share	4.71
Working Capital	132.72M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 80.51 million and capital expenditures -39.66 million, giving a free cash flow of 40.85 million.

Operating Cash Flow	80.51M
Capital Expenditures	-39.66M
Free Cash Flow	40.85M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 21.66%, with operating and profit margins of 6.74% and 3.42%.

Gross Margin	21.66%
Operating Margin	6.74%
Pretax Margin	4.37%
Profit Margin	3.42%
EBITDA Margin	9.65%
EBIT Margin	6.74%
FCF Margin	5.36%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 1.33%.

Dividend Per Share	0.04
Dividend Yield	1.33%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	1.33%
Earnings Yield	17.59%
FCF Yield	27.56%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:MED has an Altman Z-Score of 1.4 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.4
Piotroski F-Score	6